Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X-F Le

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanismsX F Le, A McWatters, J Wiener, et al.
Oncogene|May 23, 2006
HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapyX-F Wen, G Yang, W Mao, et al.
Cancer Research|July 26, 2000
Differential signaling by an anti-p185(HER2) antibody and heregulinX F Le, R Vadlamudi, A McWatters, et al.
Oncogene|January 10, 2002
Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activityX F Le, M Marcelli, A McWatters, et al.
The Journal of Biological Chemistry|July 27, 1999
Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathwayX F Le, Y Groner, S M Kornblau, et al.
Oncogene|September 5, 2012
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancersM K Y Siu, E S Y Wong, D S H Kong, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanismsX F Le, A McWatters, J Wiener, et al.
Oncogene|May 23, 2006
HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapyX-F Wen, G Yang, W Mao, et al.
Cancer Research|July 26, 2000
Differential signaling by an anti-p185(HER2) antibody and heregulinX F Le, R Vadlamudi, A McWatters, et al.
Oncogene|January 10, 2002
Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activityX F Le, M Marcelli, A McWatters, et al.
The Journal of Biological Chemistry|July 27, 1999
Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathwayX F Le, Y Groner, S M Kornblau, et al.
Oncogene|September 5, 2012
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancersM K Y Siu, E S Y Wong, D S H Kong, et al.
Pageof 2